Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026 Research and Development BMS, Scottish Medicines Consortium, colorectal cancer, oncology

Bristol Myers Squibb (BMS) has announced that its Opdivo (nivolumab) has been accepted, in combination with Yervoy (ipilimumab), by the …
News

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026 Research and Development Astellas Pharma, Scottish Medicines Consortium, Vyloy, gastric cancer, oncology

Astellas Pharma, a pharmaceutical company creating medicines to address unmet medical needs, has announced that Vyloy (zolbetuximab), in combination with …
News

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026 Research and Development Oncology, QV Bioelectronics, glioblastoma

QV Bioelectronics, a medtech business specialising in implants for cancer treatment, has announced that it has received £4.5m in funding …
News

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026 Research and Development HonorHealth Research Institute, Neurology, ischemic stroke

HonorHealth Research Institute, a research institution collaborating with a wide range of experts to produce new treatments and devices, has …
News

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026 Medical Communications, Research and Development Biotechnology, IVF, assisted reproductive technology, fertility therapeutics, infertility

By Dr Jordan Abdi Over the past two decades, demand for IVF has risen sharply as parenthood is increasingly delayed …
Feature

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026 Research and Development Barts Health NHS Trust, H.I.G. Realty, health innovation

Barts Health NHS Trust and H.I.G. Realty have announced a collaboration to launch an applied healthcare innovation building in the …
News

Sandoz’ Ondibta receives European Commission approval for diabetes

January 26, 2026 Research and Development Diabetes, Ondibta, Sandoz

Sandoz has announced that its Ondibta (insulin glargine) has received approval from the European Commission (EC) for the treatment of …
News

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026 Research and Development Complement Therapeutics, FDA, Opthalmology, geographic atrophy

Complement Therapeutics has announced that CTx001, its gene therapy treatment for geographic atrophy (GA) secondary to age-related macular degeneration (AMD), …
News

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026 Research and Development Iktos, Oncology, Pierre Fabre Laboratories

Pierre Fabre Laboratories and Iktos have announced a new collaboration intended to discover and develop new small-molecule drug candidates for …
News

European Medicines Agency recommended 104 medicines for approval in 2025

January 20, 2026 Research and Development European Medicines Agency, Rare Diseases

The European Medicines Agency (EMA) has announced data from 2025 showing that over the course of the year it recommended …
News

Biogen’s high-dose Spinraza regimen receives European Commission approval for spinal muscular atrophy

January 19, 2026 Research and Development Biogen, Neurology, Spinraza, spinal muscular atrophy

Biogen’s Spinraza (nusinersen) has received approval from the European Commission (EC) as a new high-dose regimen for the treatment of …
News

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026 Research and Development Bio-Sourcing, Oncology, Zerion Pharma, breast cancer

Bio-Sourcing and Zerion Pharma have announced that their collaboration to develop an oral form of the monoclonal antibody trastuzumab for …
News

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026 Research and Development Biocartis, Mayo Clinic, Oncology, breast cancer

Biocartis has announced a research collaboration with Mayo Clinic in the US, aiming to develop an accelerated sample-to-answer test resulting …
News

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026 Research and Development Blue Earth Therapeutics, Oncology, prostate cancer

Blue Earth Therapeutics, a clinical-stage company specialising in targeted radiotherapeutics, has announced that the first UK patient has received its …
News

Medicus Pharma’s Teverelix shows positive efficacy and safety in premenopausal women

January 13, 2026 Research and Development Endocrinology, Medicus Pharma, Teverelix

Medicus Pharma’s Teverelix has demonstrated long-lasting hormone suppression, as well as a favourable safety profile, in new study data. Teverelix …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026